chemoendocrine

chemoendocrine

/che·mo·en·do·crine/ (-en´do-krin) chemohormonal.
Mentioned in ?
References in periodicals archive ?
Adjuvant chemoendocrine therapy in postmenopausal breast cancer.
22,60,61) The International Breast Cancer Study Group (IBCSG) conducted a series of studies comparing chemoendocrine therapy to endocrine therapy alone in years before the establishment of IHC testing.
Viale G, Regan MM, Maiorano E, et al: Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: Predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Chemoendocrine therapy for premenopausal women with axillary lymph nodepositive, steroid hormone receptor-positive breast cancer.
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
of Patients Intervention Reference (eligibility) (outcome) McCarty Pop A, n 5 62 Endocrine Rx et al (4) (early stage); (Pop C) Pop B, n 5 72 (early stage); Pop C, n 5 23 (MBC) Barnes 170 patients; First-line TAM et al (5) 74% ER in MBC (51% positive by response rate) LBA Harvey 1,982 patients 26% received et al (6) endocrine Rx and 13% received combined chemoendocrine Rx Elledge 205 patients SWOG 8228, TAM et al (7) with blocks 10 mg twice a (original n 5 day (n 5 56) or 349, all ER 10 mg/[m.
Axillary lymph node scarring and the association with tumour response following neoadjuvant chemoendocrine therapy for breast cancer.